Head to Head Survey: Bio-Rad Laboratories (BIO) and Utah Medical Products (UTMD)
Bio-Rad Laboratories (NYSE: BIO) and Utah Medical Products (NASDAQ:UTMD) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.
Volatility and Risk
Bio-Rad Laboratories has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500.
Valuation & Earnings
This table compares Bio-Rad Laboratories and Utah Medical Products’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Bio-Rad Laboratories||$2.08 billion||3.22||$233.59 million||$0.50||452.52|
|Utah Medical Products||$39.60 million||7.20||$20.09 million||$3.49||21.98|
Bio-Rad Laboratories has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent recommendations and price targets for Bio-Rad Laboratories and Utah Medical Products, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Utah Medical Products||0||0||0||0||N/A|
Bio-Rad Laboratories presently has a consensus price target of $240.00, indicating a potential upside of 6.07%. Given Bio-Rad Laboratories’ higher possible upside, equities research analysts plainly believe Bio-Rad Laboratories is more favorable than Utah Medical Products.
Utah Medical Products pays an annual dividend of $1.06 per share and has a dividend yield of 1.4%. Bio-Rad Laboratories does not pay a dividend. Utah Medical Products pays out 30.4% of its earnings in the form of a dividend.
Institutional and Insider Ownership
62.8% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 66.8% of Utah Medical Products shares are owned by institutional investors. 28.3% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 9.1% of Utah Medical Products shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares Bio-Rad Laboratories and Utah Medical Products’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Utah Medical Products||32.98%||17.91%||15.95%|
Bio-Rad Laboratories beats Utah Medical Products on 8 of the 15 factors compared between the two stocks.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. As of December 31, 2016, Bio-Rad sold more than 8,000 products and services to a client base, including scientific research, healthcare, education and government customers around the world.
Utah Medical Products Company Profile
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices.
Receive News & Stock Ratings for Bio-Rad Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories Inc. and related stocks with our FREE daily email newsletter.